HIV-1 infection is associated with changes in nuclear receptor transcriptome, pro-inflammatory and lipid profile of monocytes

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Renga, Barbara ^a   Francisci, Daniela ^a   D'Amore, Claudio ^a   Schiaroli, Elisabetta ^a   Carino, Adriana ^a   Baldelli, Franco ^a   Fiorucci, Stefano ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Adhesion molecules; Chemokines; HIV infection; Nuclear receptors

Indexed keywords

ABC TRANSPORTER A1; CD36 ANTIGEN; CELL NUCLEUS RECEPTOR; FARNESOID X RECEPTOR; GLUCOCORTICOID RECEPTOR; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; LIVER X RECEPTOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PREGNANE X RECEPTOR; RETINOIC ACID RECEPTOR ALPHA; RETINOID X RECEPTOR; TRANSCRIPTOME; VITAMIN D RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LIPIDS; MALE; MIDDLE AGED; MONOCYTES; PILOT PROJECTS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTOME;

EID: 84867899821     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-274     Document Type: Article

References (30)

1. Losina E, Schackman BR, Sadownik SN, Gebo KA, Walensky RP, Chiosi JJ, Weinstein MC, Hicks PL, Aaronson WH, Moore RD, Paltiel AD, Freedberg KA. Racial and sex disparities in life expectancy losses among HIV-infected persons in the United States: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. Clin Infect Dis 2009, 49:1570-1578. 10.1086/644772, 2783631, 19845472.
2. Hunt PW, Martin JN, Sinclair E, Bredt B, Hagos E, Lampiris H, Deeks SG. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 2003, 187:1534-1543. 10.1086/374786, 12721933.
3. Appay V, Sauce D. Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol 2008, 214:231-241. 10.1002/path.2276, 18161758.
4. Tien PC, Choi AI, Zolopa AR, Benson C, Tracy R, Scherzer R, Bacchetti P, Shlipak M, Grunfeld C. Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort. J Acquir Immune Defic Syndr 2010, 55:316-322. 10.1097/QAI.0b013e3181e66216, 2955817, 20581689.
5. van Wijk JP, Cabezas MC. Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution. Int J Vasc Med 2012, 2012:201027. 3159991, 21876813.
6. Francis GA, Fayard E, Picard F, Auwerx J. Nuclear receptors and the control of metabolism. Annu Rev Physiol 2003, 65:261-311. 10.1146/annurev.physiol.65.092101.142528, 12518001.
7. Huang W, Glass CK. Nuclear receptors and inflammation control: molecular mechanisms and pathophysiological relevance. Arterioscler Thromb Vasc Biol 2010, 30:1542-1549. 10.1161/ATVBAHA.109.191189, 2911147, 20631355.
8. Levi M, Wang X, Choudhury D. Nuclear hormone receptors as therapeutic targets. Contrib Nephrol 2011, 170:209-216.
9. Renga B, Francisci D, D'Amore C, Schiaroli E, Mencarelli A, Cipriani S, Baldelli F, Fiorucci S. The HIV matrix protein p17 subverts nuclear receptors expression and induces a STAT1-dependent proinflammatory phenotype in monocytes. PLoS One 2012, 7:e35924. 10.1371/journal.pone.0035924, 3340403, 22558273.
10. Hanley TM, Viglianti GA. Nuclear receptor signaling inhibits HIV-1 replication in macrophages through multiple trans-repression mechanisms. J Virol 2011, 85:10834-10850. 10.1128/JVI.00789-11, 3187477, 21849441.
11. Renga B, Mencarelli A, Migliorati M, Distrutti E, Fiorucci S. Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation. World J Gastroenterol 2009, 15:2097-2108. 10.3748/wjg.15.2097, 2678580, 19418582.
12. Deeks SG. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med 2009, 17:118-123.
13. Vacca M, Degirolamo C, Mariani-Costantini R, Palasciano G, Moschetta A. Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome. Wiley Interdiscip Rev Syst Biol Med 2011, 3:562-587. 10.1002/wsbm.137, 21755605.
14. Bergamaschi A, Pancino G. Host hindrance to HIV-1 replication in monocytes and macrophages. Retrovirology 2010, 7:31. 10.1186/1742-4690-7-31, 2868797, 20374633.
15. Marchetti G, Cozzi-Lepri A, Merlini E, Bellistrì GM, Castagna A, Galli M, Verucchi G, Antinori A, Costantini A, Giacometti A, di Caro A, D'arminio Monforte A. Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count. AIDS 2011, 25:1385-1394. 10.1097/QAD.0b013e3283471d10, 21505312.
16. Vassallo M, Mercié P, Cottalorda J, Ticchioni M, Dellamonica P. The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: a systematic literature review. Virol J 2012, 9:174. 10.1186/1743-422X-9-174, 3495848, 22925532.
17. Wang K, Wan YJ. Nuclear receptors and inflammatory diseases. Exp Biol Med 2008, 233:496-506.
18. Feingold K, Kim MS, Shigenaga J, Moser A, Grunfeld C. Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response. Am J Physiol Endocrinol Metab 2004, 286:E201-E207.
19. Fiorucci S, Cipriani S, Baldelli F, Mencarelli A. Bile acid-activated receptors in the treatment of dyslipidemia and related disorders. Prog Lipid Res 2010, 49:171-185. 10.1016/j.plipres.2009.11.001, 19932133.
20. Modica S, Gofflot F, Murzilli S, D'Orazio A, Salvatore L, Pellegrini F, Nicolucci A, Tognoni G, Copetti M, Valanzano R, Veschi S, Mariani-Costantini R, Palasciano G, Schoonjans K, Auwerx J, Moschetta A. The intestinal nuclear receptor signature with epithelial localization patterns and expression modulation in tumors. Gastroenterology 2010, 138:636-648. 10.1053/j.gastro.2009.09.060, 19818784.
21. Popovic M, Tenner-Racz K, Pelser C, Stellbrink HJ, van Lunzen J, Lewis G, Kalyanaraman VS, Gallo RC, Racz P. Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. Proc Natl Acad Sci USA 2005, 102:14807-14812. 10.1073/pnas.0506857102, 1253583, 16199516.
22. Glass CK, Saijo K. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat Rev Immunol 2010, 10:365-376. 10.1038/nri2748, 20414208.
23. Renga B, Mencarelli A, Vavassori P, Brancaleone V, Fiorucci S. The bile acid sensor FXR regulates insulin transcription and secretion. Biochim Biophys Acta 2010, 1802:363-372. 10.1016/j.bbadis.2010.01.002, 20060466.
24. Cipriani S, Mencarelli A, Palladino G, Fiorucci S. FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats. J Lipid Res 2010, 51:771-784. 10.1194/jlr.M001602, 2842143, 19783811.
25. Gao J, Xie W. Pregnane X receptor and constitutive androstane receptor at the crossroads of drug metabolism and energy metabolism. Drug Metab Dispos 2010, 38:2091-2095. 10.1124/dmd.110.035568, 2993451, 20736325.
26. Munigoti SP, Rees A. Evidence for use of fibrates in diabetic dyslipidemia: are we looking hard enough?. Curr Opin Lipidol 2011, 22:76-77. 10.1097/MOL.0b013e328342b0e9, 21233625.
27. Fiorucci S, Cipriani S, Mencarelli A, Baldelli F, Bifulco G, Zampella A. Farnesoid X receptor agonist for the treatment of liver and metabolic disorders: focus on 6-ethyl-CDCA. Mini Rev Med Chem 2011, 11:753-762. 10.2174/138955711796355258, 21707532.
28. Fiévet C, Staels B. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis. Biochem Pharmacol 2009, 77:1316-1327. 10.1016/j.bcp.2008.11.026, 19101522.
29. Riddler SA, Smit E, Cole SR, Li R, Chmiel JS, Dobs A, Palella F, Visscher B, Evans R, Kingsley LA. Impact of HIV infection and HAART on serum lipids in men. JAMA 2003, 289:2978-2982. 10.1001/jama.289.22.2978, 12799406.
30. Masuda D, Hirano K, Oku H, Sandoval JC, Kawase R, Yuasa-Kawase M, Yamashita Y, Takada M, Tsubakio-Yamamoto K, Tochino Y, Koseki M, Matsuura F, Nishida M, Kawamoto T, Ishigami M, Hori M, Shimomura I, Yamashita S. Chylomicron remnants are increased in the postprandial state in CD36 deficiency. J Lipid Res 2009, 50:999-1011. 2666186, 18753675.